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Editorial
Prevention of depressive disorders:
towards a further reduction of the disease
burden of mental disorderseip_282 179..180
From a public health perspective, depression is one
of the most important mental disorders. It is highly
prevalent,1,2 has a high incidence3 and is associated
with a substantial loss of quality of life for patients
and their relatives,4,5 increased mortality rates,6
high levels of service use and enormous economic
costs.7–9 Major depression is currently ranked fourth
worldwide in disease burden, and it is expected to
rank first in disease burden in high-income coun-
tries by the year 2030.10 Although current treatments
are effective in treating depressive disorders, it is
estimated that treatment alone can reduce the
disease burden of depression by only about 35%,
but only in optimal conditions.11 Prevention of the
incidence of new cases of depression has been sug-
gested as a new strategy next to treatment, which
may help to further lower the disease burden.12,13
In the past 15 years, considerable progress has
been made in examining the possibilities to prevent
the onset of depressive disorders. In a recent meta-
analysis, we were able to include 19 randomized
trials examining interventions aimed at preventing
the onset of depressive disorders in participants
with no disorder at baseline,14 and currently almost
30 trials have been conducted.15 These studies
show that preventive interventions are capable of
preventing about one-quarter of the new incident
cases.
These studies vary considerably from each other,
with some studies being aimed at adolescents,
whereas others focus on adults and some on older
adults. The setting in which the studies are con-
ducted also differs considerably, ranging from
studies aimed at post-partum depression to studies
aimed at patients with general medical disorders
and primary care patients. Some studies are aimed
at universal prevention, which is aimed at the
general population or parts of the general popula-
tion, regardless of whether they are at elevated risk
of developing a disorder (e.g. school programmes or
mass media campaigns). Other studies focus on
selective prevention, which is aimed at high-risk
groups, who have not yet developed a mental disor-
der. Still other studies focus on indicated prevention
(aimed at individuals who have some symptoms
of a mental disorder but do not meet diagnostic
criteria). The interventions used in these studies
also vary considerably and include cognitive behav-
ioural interventions, interventions based on inter-
personal psychotherapy and psychoeducational
interventions. Some studies explicitly focus on the
first ever depressive disorder, whereas others allow
lifetime depressive disorders.
So, the field is still very heterogeneous in terms of
target groups, setting and type of intervention. In
our meta-analysis, we did not find high levels of
statistical heterogeneity, which may indicate that
our finding of about 25% reduction of incidence is
robust across target groups, settings and interven-
tions. It also indicates, however, that the field is
still very young, and definite conclusions about the
effects of these interventions cannot yet be drawn.
Prevention of mental disorders in general is still at
an early stage of development. Although a relatively
large number of studies have examined the possi-
bilities of preventing depressive disorders, we still
have very little knowledge about effective interven-
tions and how to apply them. Although several
studies have examined the possibilities to prevent
anxiety disorders,16–18 eating disorders19 and psy-
chotic disorders,20 this is nothing compared with the
thousands of studies that have examined treatment
of existing disorders. Although treatment studies
have examined the effects, acceptability and feasi-
bility of many different types of treatment in many
different settings, the possibilities of preventing the
onset of mental disorders have only just started to
be explored in a few dozen studies.
Research on the possibilities of preventing mental
disorders has been developed within subfields,
largely independent of other subfields and with
little exchange. Prevention of depressive disorders,
anxiety disorders, psychotic disorders, eating disor-
ders, conduct disorders in children and all fields
has been developed from research on treatments of
these disorders and epidemiological research exam-
ining each of these disorders. This has also led to
differences among subfields. For example, in the
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field of prevention of depression, many hope that
universal prevention through school programmes
will prove to be possible and feasible,21 whereas in
the field of preventing eating disorders, universal
prevention is almost impossible,13 and universal
prevention of psychotic disorders is not considered
to be possible either at this moment by most
researchers. In the field of prevention of psychotic
disorders, indicated prevention and early interven-
tions are the best options, with few possibilities for
selective prevention, whereas selective prevention
of depression is probably effective in well-chosen
target groups.14 Prevention and early intervention
of psychotic disorders are aimed at preventing
or delaying the first psychotic episode in young
people, whereas prevention of depression is also
aimed at older adults and recurrent episodes.
Despite these differences, it is time that these
subfields start working together and learn from
each other’s experiences. In the prodromal and
early phases of mental disorders, it may not yet
be completely clear which disorder will develop,
and generic preventive strategies using transdiag-
nostic approaches may be able to prevent different
types of disorders. Clinical staging provides a good
framework for the further development of these
preventive strategies.22
There is no doubt that prevention of mental
disorders is one of the major challenges for the
next decades. Prevention of depression has been
shown to be effective and feasible in demonstration
projects. Collaboration with other fields and dis-
seminating this knowledge to practice will be the
next steps in further reducing the disease burden of
mental disorders.
Pim Cuijpers
Department of Clinical Psychology and
EMGO Institute for Health and Care Research,
VU University and VU University Medical Center,
Amsterdam, The Netherlands
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